Ranexa (ranolazine) is not a nitrate. It is classified as an antianginal medication, meaning it treats chest pain from angina, but it works through a completely different mechanism than nitrates like nitroglycerin or isosorbide mononitrate. The two drugs are so distinct that Ranexa is often prescribed alongside nitrates as part of a combination therapy.
How Ranexa Differs From Nitrates
Nitrates work by relaxing and widening blood vessels, which lowers blood pressure and reduces the heart’s workload. That vasodilatory effect is why nitrates can cause headaches, dizziness, and drops in blood pressure.
Ranexa takes an entirely different approach. It belongs to a class called late sodium current inhibitors. During each heartbeat, sodium flows into heart muscle cells through tiny channels. In people with angina, those channels can stay open too long, letting excess sodium build up inside the cells. That sodium buildup triggers a chain reaction that increases calcium levels inside the cells, which stiffens the heart muscle and raises its oxygen demand. Ranexa blocks this abnormal, lingering sodium flow, which keeps intracellular calcium in check and reduces the heart’s oxygen needs without dilating blood vessels or significantly changing heart rate or blood pressure.
Chemically, the two aren’t related either. Ranolazine is a piperazine derivative with the molecular formula C₂₄H₃₃N₃O₄. Nitrates are organic compounds containing nitrate ester groups. They share no structural similarity.
Why the Confusion Exists
Both Ranexa and nitrates treat chronic angina, so it’s natural to assume they might be the same type of drug. They also sometimes appear together on the same prescription list for a patient. But treating the same condition doesn’t make them the same class of medication. Beta-blockers and calcium channel blockers also treat angina through yet another set of mechanisms. Ranexa is simply one more tool with its own distinct pharmacology.
Using Ranexa With Nitrates
Because Ranexa and nitrates work through separate pathways, they can be prescribed together safely. The FDA label specifically notes that Ranexa may be used with beta-blockers, nitrates, calcium channel blockers, and several other drug classes. In fact, Ranexa is generally intended for patients who still have angina symptoms despite already taking other medications. In one major clinical trial, about 34% of patients were also on long-acting nitrates.
Unlike the well-known and dangerous interaction between nitrates and erectile dysfunction medications (which can cause life-threatening blood pressure drops), adding Ranexa to a nitrate regimen doesn’t create that kind of hemodynamic risk because Ranexa doesn’t dilate blood vessels the way those drugs do.
How Well Ranexa Works
In the CARISA trial, a key study reviewed by the American College of Cardiology, patients taking Ranexa at either 750 mg or 1000 mg twice daily experienced roughly one fewer angina attack per week compared to placebo. That may sound modest, but for people averaging about 4.5 attacks per week at baseline, it represents a meaningful improvement in daily life. Patients on Ranexa also exercised significantly longer on a treadmill test, even after accounting for a placebo effect that itself added 92 seconds of exercise capacity.
The typical starting dose is 500 mg twice daily, which can be increased to a maximum of 1000 mg twice daily based on how well symptoms respond.
Side Effects and Precautions
Because Ranexa doesn’t affect blood vessels the way nitrates do, it avoids the classic nitrate side effects like flushing, headaches, and lightheadedness from low blood pressure. Its main concern is a mild prolongation of the QT interval, which is a measure of electrical activity in the heart. At the standard 1000 mg twice-daily dose, the average increase is about 6 milliseconds. In the 5% of patients with the highest drug levels in their blood, that prolongation reaches at least 15 milliseconds.
This QT effect means Ranexa is contraindicated in a few specific situations:
- Pre-existing QT prolongation or use of other medications that prolong the QT interval
- Any degree of liver disease, even mild, because impaired liver function roughly triples the QT-prolonging effect
- Certain medications that slow the body’s breakdown of ranolazine, including some antifungals, certain antibiotics, HIV protease inhibitors, and the calcium channel blockers diltiazem and verapamil
Grapefruit juice also interferes with how the body processes ranolazine and should be avoided while taking this medication.